NORAD is upregulated in EOC. Inhibition of NORAD, possibly through endogenously competing against hsa-miR-155-5p, can be a new tumor-suppressing strategy in EOC. (31250987)
user: 0
Pubmeds:
Login
For any questions and suggestions, write to us by mail: info@onco.io